Cynata secures European paediatric regulatory approval
Cynata Therapeutics (ASX:CYP) has received a positive opinion from the European Medicines Agency’s paediatric committee.
Cynata Therapeutics (ASX:CYP) has received a positive opinion from the European Medicines Agency’s paediatric committee.
Anax Metals (ASX:ANX) secured commitments from investors to raise approximately $6 million through a single-tranche placement.
The Australian Securities and Investments Commission has asked the Federal Court to impose a $10.3 million penalty on Mercer Super.
The US is proposing tariffs of at least 10% on imports from most major trading partners after an investigation into alleged forced labor. Mike Pompeo, former US state secretary, offers his view as investors also parse the latest development.
Vysarn (ASX:VYS) announced the acquisition of NWG Enterprises after entering into a binding share sale agreement.
Great Western Exploration (ASX:GTE) commenced an aircore drilling programme at its Diorama copper-gold target in Western Australia.
DXN (ASX:DXN) secured a landmark $8.8 million binding contract with a US-listed global neo-cloud operator.
Baidu CFO Haijian He speaks to Bloomberg's Haslinda Amin about how the company's AI-related revenue has reached 50%, explaining the benefits of its integrated services offering and the potential of its robotaxi business.
Real estate funds manager Elanor Investors Group (ASX:ENN) appointed industry veteran David McNamara as its CEO.
KPMG Australia's COO, Eileen Hogget, has reportedly stepped down from her executive post effective immediately.
Firebrick Pharma (ASX:FRE) said its patent covering the composition of Nasodine nasal spray has been granted in New Zealand.
Dan Ives, Global Head of Technology Research at Wedbush Securities, discusses the revival of the AI trade and looks ahead to the listings of OpenAI, Anthropic and SpaceX. He speaks with Haidi Stroud-Watts and Paul Allen on Bloomberg: The Asia Trade.